Chintan Shah

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Zydus Lifesciences Limited (India)(Current)

Chintan Shah is an author at Zydus Lifesciences Limited (India) specializing in pharmacology, clinical pharmacology, and serious adverse drug reactions.

Publications per year

2017–2020

Publications

Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)

Kishor Patil, Purav Trivedi, Nirali Mody et al. · Cardiovascular Diabetology · 2020 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers

Kevinkumar Kansagra, Rajendrakumar H. Jani, Nuggehally R. Srinivas et al. · Clinical Pharmacokinetics · 2017 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

1–2 of 2